Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Spectrum Pharma receives FDA approval for ready-to-use formulation of Fusilev

April 26, 2011

Hanmi Pharmaceuticals to acquire rights for KX-01 in selected Asian territories

April 26, 2011

U.S. researchers present novel Bcl-2 inhibitors for cancer

April 26, 2011

Novel FADK 1 inhibitors described by Boehringer Ingelheim

April 26, 2011

Zhejiang Beta Pharma presents new protein kinase inhibitors for cancer

April 26, 2011

KW-2450 suppresses tumor growth in vivo and advances in phase I/II trial in breast cancer

April 26, 2011

New CSF-1-R inhibitor DCC-2909 shows promise to treat bone metastasis

April 26, 2011

Oncolytics Biotech reports interim data from Reolysin trial in metastatic colorectal cancer

April 21, 2011

New inhibitors of hepatocyte growth factor receptor designed

April 21, 2011

Marina Biotech completes enrollment of first cohort in START-FAP trial of CEQ-508

April 21, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...